Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

Literature DB >> 14217630

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

A Faurbye, P J Rasch, P B Petersen, G Brandborg, H Pakkenberg.

Abstract

Keywords: ANTICONVULSANTS; CHLORPROMAZINE; DOPAMINE; EXTRAPYRAMIDAL TRACTS; MONOAMINE OXIDASE INHIBITORS; MOVEMENT DISORDERS; NEUROLOGIC MANIFESTATIONS; PHENOTHIAZINES; PSYCHOPHARMACOLOGY; PSYCHOSES; REVIEW; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS

Mesh：

Substances：

Year: 1964 PMID： 14217630 DOI： 10.1111/j.1600-0447.1964.tb05731.x

Source DB: PubMed Journal: Acta Psychiatr Scand ISSN： 0001-690X Impact factor: 6.392

Keyword Cloud
Cited

× No keyword cloud information.

34 in total

Review 1. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

Authors: Vladimir Lerner; Chanoch Miodownik
Journal: Curr Psychiatry Rep Date: 2011-08 Impact factor: 5.285

2. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

Authors: Michel C F Shamy; Clement Zai; Vincenzo S Basile; James L Kennedy; Daniel J Müller; Mario Masellis
Journal: Curr Pharmacogenomics Person Med Date: 2011-06-01

3. Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors: Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal: Neurotherapeutics Date: 2014-01 Impact factor: 7.620

Review 4. Tardive Dyskinesia: Treatment Update.

Authors: Divya Arya; Tarannum Khan; Adam J Margolius; Hubert H Fernandez
Journal: Curr Neurol Neurosci Rep Date: 2019-08-16 Impact factor: 5.081

5. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors: O Gureje
Journal: J Neurol Neurosurg Psychiatry Date: 1988-12 Impact factor: 10.154

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

Review 1. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

2. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

3. Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Review 4. Tardive Dyskinesia: Treatment Update.

5. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

6. Abnormal involuntary movements: side-effect of neuroleptic drugs.

Review 7. [Antipsychotic-induced tardive syndromes].

8. Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

Review 9. Management of tardive dyskinesia: current update.

10. What happens in the leucotomised brain? A postmortem morphological study of brains from schizophrenic patients.